Manufacturers have until May 18 to either submit a premarket approval application (PMA) for their metal-on-metal (MoM) hip products or take them off the market, the US Food and Drug Administration announced in a Feb. 18 final order1.
The agency declined to take several more extreme steps in the order that were recommended by patient safety groups, some of which were outside the scope of FDA's authority....